Danqing Guo

Dr. Danqing Guo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
DGDanqing Guo
Danqing Guo
MYMiao Yu
Miao Yu
HGHuizhi Guo
Huizhi Guo
MZMin Zeng
Min Zeng
YSYang Shao
Yang Shao
SZShunCong Zhang
ShunCong Zhang
Panax notoginseng (Burk) F. H. Chen has been a popular traditional Chinese medicine with long history for treating low back pain. Its main active ingredient, Panax notoginseng saponins (PNS), can be found in several Chinese patent medicines that are frequently used to treat blood stasis type low back pain. Intervertebral disc degeneration (IDD) is the most common cause of back pain, and the injection of PNS has been used to relieve IDD-induced back pain in clinical practice. Despite its effectiveness, the exact mechanisms of action for PNS injections remain unclear. IDD as a consequence of aging involves apoptosis of nucleus pulposus (NP) cells and imbalanced degradation of extracellular matrix (ECM) induced by several factors including oxidative stress. We hypothesized that PNS may have therapeutic effect on IDD via inhibiting apoptosis of NP cells and degradation of ECM under oxidative stress. In this study, network pharmacology was initially employed to predict the target of PNS against IDD. Subsequently, commercial PNS was analyzed by high-performance liquid chromatography to comfirm the ingrediants for in vitro and in vivo experiments. In vitro experiments were conducted on human nucleus pulposus cells, including CCK-8, RT-PCR, Western blot, immunofluorescence staining, autophagic flux detection and TUNEL assay. In vivo experiments were also performed on rats with IDD of tail discs induced by annular fibrosus needle puncture, which involved MRI, HE staining, and immunohistochemistry. Our study demonstrated the theoretical targets of PNS against IDD, including Caspase 3, MMP13, Akt, and autophagy, based on network pharmacology. Subsequently, in vitro experiments revealed that PNS attenuated cellular apoptosis of NP by suppressing the expression of cleaved-caspase 3 and the ratio of Bax/Bcl-2 under H2O2 stimulation. Autophagy was also inhibited by PNS treatment, and the protective effect was abolished with rapamycin, an autophagy inducer, indicating that autophagy inhibition was involved in the protective effect of PNS on IDD. Furthermore, Akt/mTOR pathway activation was observed in HNP cells responding to H2O2 with PNS treatment, which played a role in autophagy downregulation. PNS was also shown to promote the expression of anabolic genes such as Col2a1 and ACAN while inhibiting the expression of catabolic gene MMP13 in HNP cells. In addition, the in vivo study revealed that PNS treatment could ameliorate IDD in a puncture-induced rat tail model. The development of IDD was significantly reduced, and there was decreased MMP13 expression, as well as increased Col2a1 protein expression in NP tissues. Our study showed that PNS could protect HNP cells against apoptosis via autophagy inhibition and ameliorate disc degeneration in vivo, indicating its potential to be a therapeutic agent for IDD.

20 December 2023 in JOR SPINE
Verified
Journal Article
Open access
DGDanqing Guo
Danqing Guo
MZMin Zeng
Min Zeng
MYMiao Yu
Miao Yu
JSJingjing Shang
Jingjing Shang
JLJinxing Lin
Jinxing Lin
ZCZhenglin Cao
Zhenglin Cao
Background: Intervertebral disc degeneration (IDD) is a significant cause of low back pain and poses a significant public health concern. Genetic factors play a crucial role in IDD, highlighting the need for a better understanding of the underlying mechanisms. Aim: The aim of this study was to identify potential IDD‐related biomarkers using a comprehensive bioinformatics approach and validate them in vitro. Materials and Methods: In this study, we employed several analytical approaches to identify the key genes involved in IDD. We utilized weighted gene coexpression network analysis (WGCNA), MCODE, LASSO algorithms, and ROC curves to identify the key genes. Additionally, immune infiltrating analysis and a single‐cell sequencing dataset were utilized to further explore the characteristics of the key genes. Finally, we conducted in vitro experiments on human disc tissues to validate the significance of these key genes in IDD. Results: we obtained gene expression profiles from the GEO database (GSE23130 and GSE15227) and identified 1015 DEGs associated with IDD. Using WGCNA, we identified the blue module as significantly related to IDD. Among the DEGs, we identified 47 hub genes that overlapped with the genes in the blue module, based on criteria of |logFC| ≥ 2.0 and p .adj <0.05. Further analysis using both MCODE and LASSO algorithms enabled us to identify five key genes, of which CKAP4 and SSR1 were validated by GSE70362, demonstrating significant diagnostic value for IDD. Additionally, immune infiltrating analysis revealed that monocytes were significantly correlated with the two key genes. We also analyzed a single‐cell sequencing dataset, GSE199866, which showed that both CKAP4 and SSR1 were highly expressed in fibrocartilage chondrocytes. Finally, we validated our findings in vitro by performing real time polymerase chain reaction (RT‐PCR) and immunohistochemistry (IHC) on 30 human disc samples. Our results showed that CKAP4 and SSR1 were upregulated in degenerated disc samples. Taken together, our findings suggest that CKAP4 and SSR1 have the potential to serve as disease biomarkers for IDD.

13 August 2025 in Biogerontology
Verified
Journal Article
Closed access
PLPeijie Luo
Peijie Luo
MYMiao Yu
Miao Yu
SZShunCong Zhang
ShunCong Zhang
DGDanqing Guo
Danqing Guo